INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 178 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -88.9% | 64 | -88.8% | 0.00% | -100.0% |
| Q4 2021 | $9,000 | 0.0% | 571 | -1.4% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | – | 579 | +6333.3% | 0.00% | – |
| Q1 2021 | $0 | – | 9 | -40.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 15 | -94.6% | 0.00% | -100.0% |
| Q2 2019 | $22,000 | +450.0% | 279 | +534.1% | 0.00% | +50.0% |
| Q1 2017 | $4,000 | -81.0% | 44 | -77.6% | 0.00% | -81.8% |
| Q4 2016 | $21,000 | -44.7% | 196 | -18.3% | 0.01% | -56.0% |
| Q3 2016 | $38,000 | +660.0% | 240 | +471.4% | 0.02% | +733.3% |
| Q2 2016 | $5,000 | -37.5% | 42 | -30.0% | 0.00% | -50.0% |
| Q4 2015 | $8,000 | – | 60 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 234,375 | $23,623,000 | 22.67% |
| Boxer Capital, LLC | 600,000 | $60,474,000 | 7.47% |
| DLD Asset Management, LP | 834,600 | $84,136,000 | 5.77% |
| GREAT POINT PARTNERS LLC | 200,000 | $20,158,000 | 2.55% |
| BB BIOTECH AG | 575,719 | $58,027,000 | 1.86% |
| Elk Creek Partners, LLC | 207,657 | $20,930,000 | 1.74% |
| ALTRINSIC GLOBAL ADVISORS LLC | 277,944 | $28,014,000 | 1.34% |
| Sarissa Capital Management LP | 54,000 | $5,442,000 | 1.21% |
| QCM Cayman, Ltd. | 2,181 | $220,000 | 0.90% |
| Opus Point Partners Management, LLC | 3,534 | $356,000 | 0.78% |